Prognostic value of the pre-treatment SUVmax of <sup>18</sup>F-FDG PET/CT combined with peripheral absolute lymphocyte in patients with newly diagnosed extranodal natural killer/T-cell lymphoma.

Cancer Imaging · 2025 · PMC12139384 · PMID 40468386

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

showed a trendp = 0.051so close (0.05 < p ≤ 0.1)

Chi-square (χ 2 ) tests revealed that low ALC was significantly associated with a high EBV-DNA load ( p = 0.040), and showed a trend towards correlation with B symptoms ( p = 0.051) (Table 2 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Prognostic value of the pre-treatment SUVmax of &lt;sup&gt;18&lt;/sup&gt;F-FDG PET/CT combined with peripheral absolute lymphocyte in patients with newly diagnosed extranodal natural killer/T-cell lymphoma.

The sentences

Prognostic value of the pre-treatment SUVmax of <sup>18</sup>F-FDG PET/CT combined with peripheral absolute lymphocyte in patients with newly diagnosed extranodal natural killer/T-cell lymphoma.